Dermaself AI Powers Remote Clinical Trials for Skincare Efficacy
Milan-based beauty tech firm Dermaself now enables testing laboratories to conduct efficacy studies with up to 10,000 volunteers photographing their skin at home, expanding testing capacity and real-world data collection.
AI Skin Analysis for Personalized Routines
Dermaself, a beauty technology company based in Milan, utilizes artificial intelligence (AI) to analyze skin from a selfie. This AI measures over 60 visible skin parameters and then recommends a personalized skincare routine from a brand's product catalog, based on INCI list analysis.
Brands and retailers currently deploy this technology on their websites, in stores, and at various events. The scientific foundation for Dermaself's AI originates from Derming, an independent research institute in Monza, Italy.
Derming has over 30 years of dermatological research experience and validated the AI's skin taxonomy using more than 100,000 clinical images reviewed by board-certified dermatologists.
Expanding to Remote Efficacy Studies
The same AI measurement technology is now available to testing laboratories for conducting remote efficacy studies. This allows studies to involve up to 10,000 volunteers who can photograph their skin from home. The critical element for both personalized routine recommendations and efficacy testing is consistent skin measurement.
Dermaself's patent-pending color normalization technology adjusts for variations in light and color across images. The AI demonstrates a high repeatability of 0.92–0.93 when measuring the same skin repeatedly, ensuring consistent data collection.
This level of consistency makes the transition from recommending routines to accurately measuring skin changes in a study a natural progression for the platform.
Benefits for Brands and Laboratories
Remote studies eliminate the common limitations of traditional efficacy testing, such as the capacity of physical test sites and the need for volunteers to travel. This opens up possibilities for larger cohorts, potentially including up to 10,000 participants, allowing study size to be determined by research questions rather than logistical constraints.
Volunteers apply products and take photos in their natural home environments, providing real-life usage data. Study setup time is significantly reduced to five days. The AI ensures consistent scoring across all images, removing the variability inherent in manual grading. This approach also broadens the volunteer pool, making participation accessible to more individuals.
Dermaself clarifies that the AI automates repetitive scoring, while study design, expert evaluation, and final conclusions remain the responsibility of the testing laboratory. Volunteer facial data is irreversibly anonymized using patent-pending 3D anonymization before analysis.
Implications for Asia's Beauty Industry
Brands can access this remote testing capability by requesting their current testing laboratories to integrate Dermaself's platform. This allows brands to maintain existing partnerships while benefiting from enhanced testing protocols. For Asia's beauty industry, this technology offers a significant opportunity to accelerate product development and strengthen efficacy claims.
Brands in highly competitive markets, such as Korea and Japan, could leverage larger, real-world cohort data to substantiate product benefits more robustly. This could lead to faster market entry for new formulations and provide stronger evidence for marketing efforts in a region where consumers increasingly prioritize verified efficacy.
The ability to conduct studies with up to 10,000 volunteers also supports more comprehensive claims for diverse skin types across Asia.
Three newsletters, one newsroom.
The Beauty Brief delivers Asia's beauty week every Monday. Regulatory Radar tracks the rule changes that move markets. Trend Pulse decodes what consumers want next. All free to start.
